November 15th, 8 AM - 4 PM; Wardman Park Marriott

Following decades of no approved therapies for various forms of Nephrotic Syndrome, potentially paradigm-changing therapies are now on the horizon. Increased understanding in disease pathophysiology, regulatory approval evolutions, and breakthroughs within drug development have led to a recent surge in the number of NS clinical trials. The continued success of these potential future therapies now requires unprecedented collaborations of collective stakeholders and champions in this community.

 

This will be an action-oriented meeting bringing together various senior level stakeholders from government, clinical practice, professional societies, industry, and patients to enhance clinical trial participation.

 

Focusing on five key drivers of Nephrotic Syndrome trial recruitment:

    • Pediatric Inclusion – methods to increase pediatric inclusion in various studies
    • Study Overlap – accommodating numerous studies and patient segmentation techniques

    • Patients – registries, US and ex-US inclusion, various patient recruitment initiatives
    • Pathology – reporting practices and patient candidate identification
    • Clinicians – securing support of nephrology at large


Key attendees, Drs. Norm Stockbridge and Aliza Thompson of the FDA's Center for Drug Evaluation and Research, will be joined by other leaders in the field and NephCure to launch this meeting and further the work generated from it.

Please respond by September 17 to ensure your participation. There is no cost to attend this meeting.

For questions, please contact Chelsey Fix: CFix@NephCure.org

Registration Information

Pharma Representatives

Please book your hotel room for this event by using this link: https://book.passkey.com/e/49763588 

$0

All Other Attendees

$0

All Other Attendees #@ID1@

Total:$0.00

Your Information

Please Join:
NephCure Kidney International
Kidney Health Initiative (of The ASN)
Members of the renal pathology community
and representatives from the Division of Cardiovascular and Renal Products of FDA

Event Details

Thursday
November 15, 2018

Time 8:00 AM
Wardman Park Marriott, Washington, DC 20008
Meeting time: 8 AM - 4 PM EST. For more information, please contact Chelsey Fix: CFix@NephCure.org